Table of Contents Table of Contents
Previous Page  56 / 62 Next Page
Information
Show Menu
Previous Page 56 / 62 Next Page
Page Background

Phase II study of Maintenance

Pembrolizumab in ES-SCLC in 1L

J Clin Oncol 35, 2017 (suppl; abstr 8504)